MYC and cancer: For example, although myc has been recognised as a “most wanted” target for the treatment of cancer, it has been considered undruggable over a long period of time, primarily due to its location in the nucleus, the absence of a well‐defined ligand‐binding domain, and the physiological functions that are necessary for maintaining normal tissues.[65, 66] However, despite the genetic data obtained in vivo, there is still much debate on the therapeutic benefits of targeting c‐MYC.